PD-L1 testing in triple negative breast cancer

被引：0
|
作者：
Dobritoiu, F. [1 ,2 ]
Chefani, A. [2 ]
Billingham, K. [3 ]
Chenard, M. [4 ]
Vaziri, R. [5 ]
Lacroix-Triki, M. [6 ]
Waydelich, A.
Erb, G.
Toro, P. [7 ]
Wedden, S. [2 ,8 ]
D'Arrigo, C. [2 ]
机构：
[1] Emergency Univ Hosp, Bucharest, Romania
[2] Poundbury Canc Inst, Dorchester, England
[3] Great Western Hosp Swindon, Swindon, Wilts, England
[4] CHU Strasbourg, Dept Pathol, Strasbourg, France
[5] Worcestershire Acute Hosp, Dept Pathol, Worcester, England
[6] Gustave Roussy Canc Campus, Dept Pathol, Villejuif, France
[7] Roche Diagnost, Roche TD, EMEA LATAM, Barcelona, Spain
[8] CADQASCIC, Dorchester, England
来源：
VIRCHOWS ARCHIV | 2019年 / 475卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-04-011
引用
收藏
页码：S17 / S18
页数：2
相关论文
共 50 条
  • [1] Harmonizing PD-L1 testing in metastatic triple negative breast cancer
    Giugliano, Federica
    Antonarelli, Gabriele
    Tarantino, Paolo
    Cortes, Javier
    Rugo, Hope S.
    Curigliano, Giuseppe
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (03) : 345 - 348
  • [2] Tissue Selection for PD-L1 Testing in Triple Negative Breast Cancer (TNBC)
    Dobritoiu, Florin
    Baltan, Adelina
    Chefani, Alina
    Billingham, Kim
    Chenard, Marie-Pierrette
    Vaziri, Reza
    Lacroix-Triki, Magali
    Waydelich, Anne
    Erb, Gilles
    Andersson, Emilia
    Canamero, Marta
    Toro, Paula
    Wedden, Sarah
    D'Arrigo, Corrado
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022, 30 (08) : 549 - 556
  • [3] External quality assessment for PD-L1 testing in triple negative breast cancer
    Warrick, N.
    Khalid, S.
    Dodson, A.
    Parry, S.
    [J]. VIRCHOWS ARCHIV, 2020, 477 : S55 - S55
  • [4] PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey
    Cerbelli, Bruna
    Cirillo, Alessio
    Pomati, Giulia
    Pernazza, Angelina
    Ascione, Andrea
    Pisegna, Simona
    Pisano, Annalinda
    Leopizzi, Martina
    Pignataro, Maria Gemma
    Costarelli, Leopoldo
    Mule, Antonino
    Vecchione, Andrea
    Catalano, Piera
    Coppola, Luigi
    Perrone, Giuseppe
    Perracchio, Letizia
    Anemona, Lucia
    Mastracchio, Antonio
    Nardi, Stefano
    Reitano, Renato
    Massari, Annalisa
    Grillo, Lucia Rosalba
    Liberati, Fabrizio
    Della Rocca, Carlo
    Marchetti, Paolo
    Botticelli, Andrea
    D'Amati, Giulia
    [J]. TUMORI JOURNAL, 2024, 110 (01): : 44 - 48
  • [5] PD-L1 Expression in Triple-Negative Breast Cancer
    Mittendorf, Elizabeth A.
    Philips, Anne V.
    Meric-Bernstam, Funda
    Qiao, Na
    Wu, Yun
    Harrington, Susan
    Su, Xiaoping
    Wang, Ying
    Gonzalez-Angulo, Ana M.
    Akcakanat, Argun
    Chawla, Akhil
    Curran, Michael
    Hwu, Patrick
    Sharma, Padmanee
    Litton, Jennifer K.
    Molldrem, Jeffrey J.
    Alatrash, Gheath
    [J]. CANCER IMMUNOLOGY RESEARCH, 2014, 2 (04) : 361 - 370
  • [6] PD-L1 status of triple negative breast cancer in Russia
    Frank, G.
    Kuznetsova, O.
    Zavalishina, L.
    Andreeva, Y.
    Moskvina, L.
    Karaseva, V.
    Tjulandin, S.
    [J]. VIRCHOWS ARCHIV, 2020, 477 : S232 - S232
  • [7] PD-L1 testing in breast cancer
    Horii, Rie
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1361 - S1361
  • [8] PD-L1 expression in Triple Negative Breast Cancer: a study of an Iraqi population
    Keorges, Gina James
    [J]. JOURNAL OF MEDICAL SCIENCE, 2023, 92 (01): : 81 - 85
  • [9] Correlation of PD-L1 Protein and mRNA Expression in triple negative Breast Cancer
    Schueler
    Bauer, M.
    Kaufhold, S.
    Kantelhardt, E. J.
    Thomssen, C.
    Vetter, M.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (06) : E38 - E39
  • [10] The risk of PD-L1 expression misclassification in triple-negative breast cancer
    Ben Dori, Shani
    Aizic, Asaf
    Zubkov, Asia
    Tsuriel, Shlomo
    Sabo, Edmond
    Hershkovitz, Dov
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (02) : 297 - 305
12345